Literature DB >> 9843832

Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice.

A J Palazzo1, S P Jones, W G Girod, D C Anderson, D N Granger, D J Lefer.   

Abstract

Previous studies have demonstrated that circulating neutrophils (PMNs) contribute to the pathophysiology of myocardial ischemia-reperfusion (MI/R) injury. PMN-endothelial cell interactions are highly regulated by adhesive interactions between PMN CD11/CD18 and coronary endothelial cell intercellular adhesion molecule-1 (ICAM-1). We investigated the effects of MI/R in wild-type, CD18-, and ICAM-1-deficient (-/-) mice. Wild-type (n = 6), CD18 -/- (n = 6), and ICAM-1 -/- (n = 6) mice were subjected to 30 min of myocardial ischemia and 120 min of reperfusion to determine the extent of PMN infiltration and myocardial cell necrosis. Myocardial infarction (% of the area at risk) was 45.1 +/- 5.9 in wild-type mouse hearts. In contrast, the extent of myocardial infarction was significantly (P < 0.05) reduced in the CD18 (19.3 +/- 5.1%)- and ICAM-1 (17.9 +/- 3.2%)-deficient mice. Similarly, PMN infiltration into the ischemic-reperfused myocardium was attenuated by 54% in the CD18 -/- mice and by 32% in ICAM-1 -/- mice compared with wild-type hearts. Deficiency in either CD18 or ICAM-1 expression results in a marked reduction in PMN accumulation and myocardial necrosis after acute MI/R.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843832     DOI: 10.1152/ajpheart.1998.275.6.H2300

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.

Authors:  Y Gao; S Lecker; M J Post; A J Hietaranta; J Li; R Volk; M Li; K Sato; A K Saluja; M L Steer; A L Goldberg; M Simons
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice.

Authors:  Tibor Kempf; Alexander Zarbock; Christian Widera; Stefan Butz; Anika Stadtmann; Jan Rossaint; Matteo Bolomini-Vittori; Mortimer Korf-Klingebiel; L Christian Napp; Birte Hansen; Anna Kanwischer; Udo Bavendiek; Gernot Beutel; Martin Hapke; Martin G Sauer; Carlo Laudanna; Nancy Hogg; Dietmar Vestweber; Kai C Wollert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

3.  Intravital 2-photon imaging of leukocyte trafficking in beating heart.

Authors:  Wenjun Li; Ruben G Nava; Alejandro C Bribriesco; Bernd H Zinselmeyer; Jessica H Spahn; Andrew E Gelman; Alexander S Krupnick; Mark J Miller; Daniel Kreisel
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

4.  Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.

Authors:  J H Erlich; E M Boyle; J Labriola; J C Kovacich; R A Santucci; C Fearns; E N Morgan; W Yun; T Luther; O Kojikawa; T R Martin; T H Pohlman; E D Verrier; N Mackman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 5.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

6.  The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.

Authors:  Fengxin Lu; Stacey M Fernandes; Alvin E Davis
Journal:  Cardiovasc Pathol       Date:  2012-06-16       Impact factor: 2.185

Review 7.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

Review 8.  Targeting inflammatory pathways in myocardial infarction.

Authors:  Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Eur J Clin Invest       Date:  2013-06-17       Impact factor: 4.686

9.  Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice.

Authors:  Aksam Merched; Katherine Tollefson; Lawrence Chan
Journal:  Cardiovasc Res       Date:  2009-10-20       Impact factor: 10.787

10.  Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.

Authors:  Rafal Pawlinski; Michael Tencati; Craig R Hampton; Tetsuro Shishido; Tara A Bullard; Liam M Casey; Patricia Andrade-Gordon; Matthias Kotzsch; Denise Spring; Thomas Luther; Jun-ichi Abe; Timothy H Pohlman; Edward D Verrier; Burns C Blaxall; Nigel Mackman
Journal:  Circulation       Date:  2007-10-29       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.